About the deal
Capitalmind Investec acted as exclusive financial advisor to Baccinex on the sale to Adragos Pharma.
Baccinex is a Swiss-based CDMO specializing in aseptic fill-finish services for liquid and lyophilized vials. With over 20 years of experience, Baccinex operates an EU-GMP and US FDA-certified facility in Courroux (JU), Switzerland, delivering high-quality pharmaceutical solutions tailored to the unique needs of its clients. The company’s commitment to excellence and innovation has established it as a trusted partner in the pharmaceutical industry. Baccinex is renowned for its focus on batches for clinical studies as well as the production of small-to-medium scale commercial batches, offering world-class quality and reliability to its pharmaceutical clients.
Adragos is a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, Germany. With a network of six manufacturing sites across Europe and Japan, Adragos offers comprehensive pharmaceutical services, supporting clients from development through to commercial production.
With the acquisition of Baccinex, Adragos is now in a position to offer customers cutting-edge services in the field of sterile manufacturing. The transaction marks a pivotal step in the expansion of its global network. The acquisition of Baccinex aligns seamlessly with Adragos’ strategy to build a world-class manufacturing network that provides tailored solutions to meet the evolving needs of its customers.
Dr. Ursula Bausch will continue to lead Baccinex as CEO, ensuring continuity in operations and leveraging her extensive expertise in sterile manufacturing. She will also remain a minority shareholder in the company, reflecting her strong commitment to its continued success as part of Adragos.
What we did
The Capitalmind Investec team has advised the owner of Baccinex throughout the entire M&A process to the successful closure of the transaction, including:
- Preparation of business plan and marketing materials
- Identification of potential buyers (strategic and financial)
- Market approach and realization of a competitive sales process
- Preparation and support of due diligence
- Conducting price negotiations
- Support in negotiations of the legal documentation
- Coordination of all involved parties, incl. legal and tax advisors
“Capitalmind Investec managed the entire transaction process in a highly professional manner and showed very high availability and responsiveness to our needs. Thanks to their international network and deep industry insights in the pharma services sector, we could evaluate multiple partner options and realize a strong transaction result with an internationally leading CDMO providing close strategic synergies and continued growth for Baccinex.”
Dr. Ursula Bausch, founder of Baccinex
